Alex Man-Hei Yip
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alex Man-Hei Yip has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Kenneth Kam-Wing Lo
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Hong Kong, P. R. China
9 shared publications - Justin Shum
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Hong Kong, P. R. China
5 shared publications - Lawrence Cho-Cheung Lee
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
4 shared publications - Peter Kam-Keung Leung
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
3 shared publications Hua‐Wei Liu
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P.R. China
2 shared publicationsJia-Hao Wang
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Hong Kong, P. R. China
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (27) , 28238-28253
Enzyme-Responsive Chemiluminescent Probes Assembled with Iridium(III) Photosensitizers via Host–Guest Chemistry for Chemiluminescence-Induced Photodynamic Therapy
Photodynamic therapy (PDT) is effective for localized cancers, but its reliance on external light limits treatment depth and uniformity. Herein, we report a programmable supramolecular chemiluminescence (CL)-induced PDT platform that generates reactive oxygen species (ROS) in the absence of light irradiation and displays intrinsic cancer selectivity. This platform is constructed through the supramolecular interaction between enzyme-responsive chemiluminescent spiroadamantyl phenoxy-1,2-dioxetane probes (ADOP, ADOE, and ADOG) and luminescent iridium(III) complexes bearing a trimethyl-β-cyclodextrin (TMCD) host [Ir(N∧C)2(bpy-TMCD)](Cl) (HN∧C = 2-phenylpyridine (Hppy) (1a), 2-phenylquinoline (Hpq) (2a), and 2-(1-naphthyl)benzothiazole (Hbsn) (3a)). The chemiluminescent probes exhibited CL upon reaction with alkaline phosphatase (ALP), porcine liver esterase (PLE), and β-galactosidase (β-gal); while the iridium(III) complexes showed intense phosphorescence with efficient singlet oxygen production, distinct intracellular localization, and tunable (photo)cytotoxicity. In aqueous solutions, mixing the chemiluminescent probes with TMCD-tagged iridium(III) complexes afforded supramolecular adducts that, upon enzyme activation, underwent chemiluminescence resonance energy transfer (CRET) from the dioxetane donors to the iridium(III) acceptors. Remarkably, the ALP-responsive conjugate formed from probe ADOP and complex 3a (adduct ADOP–3a) selectively generated ROS and elicited potent cytotoxicity in cancerous HeLa cells and spheroids under light-free conditions, with apoptosis as the predominant cell death pathway, while remaining noncytotoxic in normal HEK293 cells. This modular platform couples supramolecular host–guest assembly, enzyme-specific activation, and CRET-induced ROS generation to overcome the limitations of conventional PDT, enabling cancer-selective, light-free therapy.
- 30 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (27) , 28238-28253
Open AccessEnzyme-Responsive Chemiluminescent Probes Assembled with Iridium(III) Photosensitizers via Host–Guest Chemistry for Chemiluminescence-Induced Photodynamic Therapy
Photodynamic therapy (PDT) is effective for localized cancers, but its reliance on external light limits treatment depth and uniformity. Herein, we report a programmable supramolecular chemiluminescence (CL)-induced PDT platform that generates reactive oxygen species (ROS) in the absence of light irradiation and displays intrinsic cancer selectivity. This platform is constructed through the supramolecular interaction between enzyme-responsive chemiluminescent spiroadamantyl phenoxy-1,2-dioxetane probes (ADOP, ADOE, and ADOG) and luminescent iridium(III) complexes bearing a trimethyl-β-cyclodextrin (TMCD) host [Ir(N∧C)2(bpy-TMCD)](Cl) (HN∧C = 2-phenylpyridine (Hppy) (1a), 2-phenylquinoline (Hpq) (2a), and 2-(1-naphthyl)benzothiazole (Hbsn) (3a)). The chemiluminescent probes exhibited CL upon reaction with alkaline phosphatase (ALP), porcine liver esterase (PLE), and β-galactosidase (β-gal); while the iridium(III) complexes showed intense phosphorescence with efficient singlet oxygen production, distinct intracellular localization, and tunable (photo)cytotoxicity. In aqueous solutions, mixing the chemiluminescent probes with TMCD-tagged iridium(III) complexes afforded supramolecular adducts that, upon enzyme activation, underwent chemiluminescence resonance energy transfer (CRET) from the dioxetane donors to the iridium(III) acceptors. Remarkably, the ALP-responsive conjugate formed from probe ADOP and complex 3a (adduct ADOP–3a) selectively generated ROS and elicited potent cytotoxicity in cancerous HeLa cells and spheroids under light-free conditions, with apoptosis as the predominant cell death pathway, while remaining noncytotoxic in normal HEK293 cells. This modular platform couples supramolecular host–guest assembly, enzyme-specific activation, and CRET-induced ROS generation to overcome the limitations of conventional PDT, enabling cancer-selective, light-free therapy.
- Open Access
- 7 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Revisiting Cu(I)‐Dppm Chemistry: Bright Thermally Activated Delayed Fluorescence Luminescence, Anion Dependance, Mechanochromism, and Singlet Oxygen Generation of a Dinuclear Cu(I) Homoleptic Complex
The one‐step syntheses of highly luminescent Cu(I) dimetallic complexes are reported using Cu(I) salts and the commercially available dppm ligand. Three crystalline phases A – C , obtained either with PF 6 − ( A and B : [Cu 2 (μ 2 ‐dppm) 3 ](PF 6 ) 2 ) or TEF − ( C : [Cu 2 (μ 2 ‐dppm) 3 ](TEF) 2 ) anions, display distinct conformations and crystal packings that strongly influence photophysical properties. All phases show intense solid‐state thermally activated delayed fluorescence with room temperature quantum yields of nearly 100%. Emission energies and decay times are modulated by packing effects. Phases A and B exhibit pronounced mechanochromic luminescence upon gentle grinding, while phase C is mechanically insensitive, presumably due to its bulky and flexible counter‐anions. Density functional calculation/time‐dependent density functional calculations suggest that crystal packing impacts the structural molecular relaxation, in agreement with mechanochromic behaviors. In aerated CH 2 Cl 2 , these complexes generate singlet oxygen with quantum yield of up to 30%, highlighting their potential as photosensitizers.
- 7 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Open AccessRevisiting Cu(I)‐Dppm Chemistry: Bright Thermally Activated Delayed Fluorescence Luminescence, Anion Dependance, Mechanochromism, and Singlet Oxygen Generation of a Dinuclear Cu(I) Homoleptic Complex
The one‐step syntheses of highly luminescent Cu(I) dimetallic complexes are reported using Cu(I) salts and the commercially available dppm ligand. Three crystalline phases A – C , obtained either with PF 6 − ( A and B : [Cu 2 (μ 2 ‐dppm) 3 ](PF 6 ) 2 ) or TEF − ( C : [Cu 2 (μ 2 ‐dppm) 3 ](TEF) 2 ) anions, display distinct conformations and crystal packings that strongly influence photophysical properties. All phases show intense solid‐state thermally activated delayed fluorescence with room temperature quantum yields of nearly 100%. Emission energies and decay times are modulated by packing effects. Phases A and B exhibit pronounced mechanochromic luminescence upon gentle grinding, while phase C is mechanically insensitive, presumably due to its bulky and flexible counter‐anions. Density functional calculation/time‐dependent density functional calculations suggest that crystal packing impacts the structural molecular relaxation, in agreement with mechanochromic behaviors. In aerated CH 2 Cl 2 , these complexes generate singlet oxygen with quantum yield of up to 30%, highlighting their potential as photosensitizers.
- 4 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (98) , 19461-19464
A matrix metalloproteinase-responsive iridium( iii )-based hydrogel for cancer cell-specific imaging and lysosome-targeted photodynamic therapy
A matrix metalloproteinase-sensitive iridium( iii )-based hydrogel selectively delivered lysosome-targeting iridium( iii ) complexes to cancer cells in response to elevated enzyme activity, offering a promising strategy for cancer imaging and therapy.
- 4 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (98) , 19461-19464
A matrix metalloproteinase-responsive iridium( iii )-based hydrogel for cancer cell-specific imaging and lysosome-targeted photodynamic therapy
A matrix metalloproteinase-sensitive iridium( iii )-based hydrogel selectively delivered lysosome-targeting iridium( iii ) complexes to cancer cells in response to elevated enzyme activity, offering a promising strategy for cancer imaging and therapy.
- Open Access
- 17 July 2025
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 64 (29) , 15064-15077
Luminescent Cyclometalated Iridium(III) Polypyridine Complexes Modified with a Dendritic Guanidinium Moiety as Molecular Glues for Combined Chemo-Photodynamic Therapy
We report herein three cyclometalated iridium(III) polypyridine complexes appended with a dendritic guanidinium unit [Ir(N^C)2(bpy-Gu9)](Cl)10 (bpy-Gu9 = 4-(N-(3,4,5-tris(2-(2-(2-(4-((3,4,5-tris(2-(2-(2-guanidinoethoxy)ethoxy)ethoxy)benz-amido)methyl)-1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)phenylcarbonyl)aminomethyl)-4'-methyl-2,2'-bipyridine; HN^C = 2-phenylpyridine (Hppy) (1a), 2-phenylquinoline (Hpq) (2a), and 2-(1-naphthyl)benzothiazole (Hbsn) (3a)) as molecular glues. Their guanidinium-free counterparts [Ir(N^C)2(bpy-C4)](Cl) (bpy-C4 = 4-(N-(n-propylcarbonyl)aminomethyl)-4'-methyl-2,2'-bipyridine; HN^C = Hppy (1b), Hpq (2b), and Hbsn (3b)) were also isolated. Irradiation of the complexes led to intense greenish-yellow to red emission. Additionally, the cellular uptake and (photo)cytotoxic effects of the complexes were investigated. Protein-binding studies showed that the decacationic complexes 1a-3a exhibited high binding affinity toward bovine serum albumin (BSA). Complex 1a was utilized to modify doxorubicin (DOX)-loaded, glutathione (GSH)-responsive BSA nanoparticles (DOX/SSBNPs), affording Ir-DOX/SSBNPs. Notably, functionalization of DOX/SSBNPs with the complex reversed the surface charge from negative to positive. The size of Ir-DOX/SSBNPs decreased significantly upon incubation with GSH as a result of efficient DOX release. The positively charged Ir-DOX/SSBNPs showed efficient cellular uptake in HeLa cells, which proved to be crucial for their effectiveness in combined chemo-photodynamic therapy. These results showed that iridium(III)-based molecular glues can be employed for drug delivery and combined chemo-photodynamic therapy.
- 17 July 2025
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 64 (29) , 15064-15077
Open AccessLuminescent Cyclometalated Iridium(III) Polypyridine Complexes Modified with a Dendritic Guanidinium Moiety as Molecular Glues for Combined Chemo-Photodynamic Therapy
We report herein three cyclometalated iridium(III) polypyridine complexes appended with a dendritic guanidinium unit [Ir(N^C)2(bpy-Gu9)](Cl)10 (bpy-Gu9 = 4-(N-(3,4,5-tris(2-(2-(2-(4-((3,4,5-tris(2-(2-(2-guanidinoethoxy)ethoxy)ethoxy)benz-amido)methyl)-1H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)phenylcarbonyl)aminomethyl)-4'-methyl-2,2'-bipyridine; HN^C = 2-phenylpyridine (Hppy) (1a), 2-phenylquinoline (Hpq) (2a), and 2-(1-naphthyl)benzothiazole (Hbsn) (3a)) as molecular glues. Their guanidinium-free counterparts [Ir(N^C)2(bpy-C4)](Cl) (bpy-C4 = 4-(N-(n-propylcarbonyl)aminomethyl)-4'-methyl-2,2'-bipyridine; HN^C = Hppy (1b), Hpq (2b), and Hbsn (3b)) were also isolated. Irradiation of the complexes led to intense greenish-yellow to red emission. Additionally, the cellular uptake and (photo)cytotoxic effects of the complexes were investigated. Protein-binding studies showed that the decacationic complexes 1a-3a exhibited high binding affinity toward bovine serum albumin (BSA). Complex 1a was utilized to modify doxorubicin (DOX)-loaded, glutathione (GSH)-responsive BSA nanoparticles (DOX/SSBNPs), affording Ir-DOX/SSBNPs. Notably, functionalization of DOX/SSBNPs with the complex reversed the surface charge from negative to positive. The size of Ir-DOX/SSBNPs decreased significantly upon incubation with GSH as a result of efficient DOX release. The positively charged Ir-DOX/SSBNPs showed efficient cellular uptake in HeLa cells, which proved to be crucial for their effectiveness in combined chemo-photodynamic therapy. These results showed that iridium(III)-based molecular glues can be employed for drug delivery and combined chemo-photodynamic therapy.
- Open Access
- 28 January 2025
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
- Vol. 12 (6) , 2266-2279
Luminescent iridium(iii) 2-cyanobenzothiazole complexes as site-specific labels to afford peptide-based phosphorogenic probes and hydrogels for enzyme activity sensing, cancer imaging and photodynamic therapy
Iridium(iii) 2-cyanobenzothiazole complexes were designed as N-terminal cysteine-specific labels to prepare peptide-based phosphorogenic probes and hydrogels for matrix metalloproteinase-2/9 sensing, cancer imaging and photocytotoxic applications.
- 28 January 2025
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
- Vol. 12 (6) , 2266-2279
Open AccessLuminescent iridium(iii) 2-cyanobenzothiazole complexes as site-specific labels to afford peptide-based phosphorogenic probes and hydrogels for enzyme activity sensing, cancer imaging and photodynamic therapy
Iridium(iii) 2-cyanobenzothiazole complexes were designed as N-terminal cysteine-specific labels to prepare peptide-based phosphorogenic probes and hydrogels for matrix metalloproteinase-2/9 sensing, cancer imaging and photocytotoxic applications.
- 9 September 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (37) , 25589-25599
Exploiting the Potential of Iridium(III) bis-Nitrone Complexes as Phosphorogenic Bifunctional Reagents for Phototheranostics
Cross-linking strategies have found wide applications in chemical biology, enabling the labeling of biomolecules and monitoring of protein–protein interactions. Nitrone exhibits remarkable versatility and applicability in bioorthogonal labeling due to its high reactivity with strained alkynes via the strain-promoted alkyne–nitrone cycloaddition (SPANC) reaction. In this work, four cyclometalated iridium(III) polypyridine complexes functionalized with two nitrone units were designed as novel phosphorogenic bioorthogonal reagents for bioimaging and phototherapeutics. The complexes showed efficient emission quenching, which is attributed to an efficient nonradiative decay pathway via the low-lying T1/S0 minimum energy crossing point (MECP), as revealed by computational studies. However, the complexes displayed significant emission enhancement and lifetime extension upon reaction with (1R,8S,9s)-bicyclo[6.1.0]non-4-yne (BCN) derivatives. In particular, they showed a remarkably higher reaction rate toward a bis-cyclooctyne derivative (bis-BCN) compared with its monomeric counterpart (mono-BCN). Live-cell imaging and (photo)cytotoxicity studies revealed higher photocytotoxicity in bis-BCN-pretreated cells, which is ascribed to the enhanced singlet oxygen (1O2) photosensitization resulting from the elimination of the nitrone-associated quenching pathway. Importantly, the cross-linking properties and enhanced reactivity of the complexes make them highly promising candidates for the development of hydrogels and stapled/cyclized peptides, offering intriguing photophysical, photochemical, and biological properties. Notably, a nanosized hydrogel (2-gel) demonstrated potential as a drug delivery system, while a stapled peptide (2-bis-pDIKK) exhibited p53-Mdm2 inhibitory activity related to apoptosis and a cyclized peptide (2-bis-RGD) showed cancer selectivity.
- 9 September 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (37) , 25589-25599
Exploiting the Potential of Iridium(III) bis-Nitrone Complexes as Phosphorogenic Bifunctional Reagents for Phototheranostics
Cross-linking strategies have found wide applications in chemical biology, enabling the labeling of biomolecules and monitoring of protein–protein interactions. Nitrone exhibits remarkable versatility and applicability in bioorthogonal labeling due to its high reactivity with strained alkynes via the strain-promoted alkyne–nitrone cycloaddition (SPANC) reaction. In this work, four cyclometalated iridium(III) polypyridine complexes functionalized with two nitrone units were designed as novel phosphorogenic bioorthogonal reagents for bioimaging and phototherapeutics. The complexes showed efficient emission quenching, which is attributed to an efficient nonradiative decay pathway via the low-lying T1/S0 minimum energy crossing point (MECP), as revealed by computational studies. However, the complexes displayed significant emission enhancement and lifetime extension upon reaction with (1R,8S,9s)-bicyclo[6.1.0]non-4-yne (BCN) derivatives. In particular, they showed a remarkably higher reaction rate toward a bis-cyclooctyne derivative (bis-BCN) compared with its monomeric counterpart (mono-BCN). Live-cell imaging and (photo)cytotoxicity studies revealed higher photocytotoxicity in bis-BCN-pretreated cells, which is ascribed to the enhanced singlet oxygen (1O2) photosensitization resulting from the elimination of the nitrone-associated quenching pathway. Importantly, the cross-linking properties and enhanced reactivity of the complexes make them highly promising candidates for the development of hydrogels and stapled/cyclized peptides, offering intriguing photophysical, photochemical, and biological properties. Notably, a nanosized hydrogel (2-gel) demonstrated potential as a drug delivery system, while a stapled peptide (2-bis-pDIKK) exhibited p53-Mdm2 inhibitory activity related to apoptosis and a cyclized peptide (2-bis-RGD) showed cancer selectivity.
- 22 March 2019
- Published by Wiley in Chemistry – A European Journal
- Vol. 25 (38) , 8970-8974
Luminescent Rhenium(I)–Polypyridine Complexes Appended with a Perylene Diimide or Benzoperylene Monoimide Moiety: Photophysics, Intracellular Sensing, and Photocytotoxic Activity
This communication reports novel luminescent rhenium(I)–polypyridine complexes appended with a perylene diimide (PDI) or benzoperylene monoimide (BPMI) moiety through a non‐conjugated linker. The photophysical and photochemical properties originating from the interactions of the metal polypyridine and perylene units were exploited to afford new cellular reagents with thiol‐sensing capability and excellent photocytotoxic activity.
- 22 March 2019
- Published by Wiley in Chemistry – A European Journal
- Vol. 25 (38) , 8970-8974
Luminescent Rhenium(I)–Polypyridine Complexes Appended with a Perylene Diimide or Benzoperylene Monoimide Moiety: Photophysics, Intracellular Sensing, and Photocytotoxic Activity
This communication reports novel luminescent rhenium(I)–polypyridine complexes appended with a perylene diimide (PDI) or benzoperylene monoimide (BPMI) moiety through a non‐conjugated linker. The photophysical and photochemical properties originating from the interactions of the metal polypyridine and perylene units were exploited to afford new cellular reagents with thiol‐sensing capability and excellent photocytotoxic activity.
- 1 October 2016
- Published by Elsevier in Biomaterials
- Vol. 103, 305-313
Installing an additional emission quenching pathway in the design of iridium(III)-based phosphorogenic biomaterials for bioorthogonal labelling and imaging
- 1 October 2016
- Published by Elsevier in Biomaterials
- Vol. 103, 305-313
Installing an additional emission quenching pathway in the design of iridium(III)-based phosphorogenic biomaterials for bioorthogonal labelling and imaging
- 19 June 2015
- Published by Wiley in Chemistry – A European Journal
- Vol. 21 (30) , 10729-10740
Bioorthogonal Labeling, Bioimaging, and Photocytotoxicity Studies of Phosphorescent Ruthenium(II) Polypyridine Dibenzocyclooctyne Complexes
The synthesis, characterization, photophysics, lipophilicity, and cellular properties of new phosphorescent ruthenium(II) polypyridine complexes functionalized with a dibenzocyclooctyne (DIBO) or amine moiety [Ru(N^N)2(L)](PF6)2 are reported (L=4‐(13‐N‐(3,4:7,8‐dibenzocyclooctyne‐5‐oxycarbonyl) amino‐4,7,10‐trioxa‐tridecanyl‐aminocarbonyl‐oxy‐methyl)‐4′‐methyl‐2,2′‐bipyridine bpy‐DIBO, N^N=2,2′‐bipyridine bpy (1 a), 1,10‐phenanthroline phen (2 a); L=4‐(13‐amino‐4,7,10‐trioxa‐tridecanylaminocarbonyl‐oxy‐methyl)‐4′‐methyl‐2,2′‐bipyridine bpy‐NH2, N^N=bpy (1 b), phen (2 b)). The strain‐promoted alkyne–azide cycloaddition (SPAAC) reaction of the DIBO complexes 1 a and 2 a with benzyl azide were studied. Also, the DIBO complexes 1 a and 2 a can selectively label N‐azidoglycans located on the surface of CHO‐K1 and A549 cells that were pretreated with 1,3,4,6‐tetra‐O‐acetyl‐N‐azidoacetyl‐D‐mannosamine (Ac4ManNAz). Additionally, the intracellular trafficking and localization of these biomolecules were monitored using laser‐scanning confocal microscopy. Interestingly, the biolabeling and cellular uptake efficiency of the DIBO complexes 1 a and 2 a were cell‐line dependent, as revealed by flow cytometry and ICP‐MS. Furthermore, the complexes showed good biocompatibility toward the Ac4ManNAz‐pretreated cells in the dark, but exhibited photoinduced cytotoxicity due to the generation of singlet oxygen.
- 19 June 2015
- Published by Wiley in Chemistry – A European Journal
- Vol. 21 (30) , 10729-10740
Bioorthogonal Labeling, Bioimaging, and Photocytotoxicity Studies of Phosphorescent Ruthenium(II) Polypyridine Dibenzocyclooctyne Complexes
The synthesis, characterization, photophysics, lipophilicity, and cellular properties of new phosphorescent ruthenium(II) polypyridine complexes functionalized with a dibenzocyclooctyne (DIBO) or amine moiety [Ru(N^N)2(L)](PF6)2 are reported (L=4‐(13‐N‐(3,4:7,8‐dibenzocyclooctyne‐5‐oxycarbonyl) amino‐4,7,10‐trioxa‐tridecanyl‐aminocarbonyl‐oxy‐methyl)‐4′‐methyl‐2,2′‐bipyridine bpy‐DIBO, N^N=2,2′‐bipyridine bpy (1 a), 1,10‐phenanthroline phen (2 a); L=4‐(13‐amino‐4,7,10‐trioxa‐tridecanylaminocarbonyl‐oxy‐methyl)‐4′‐methyl‐2,2′‐bipyridine bpy‐NH2, N^N=bpy (1 b), phen (2 b)). The strain‐promoted alkyne–azide cycloaddition (SPAAC) reaction of the DIBO complexes 1 a and 2 a with benzyl azide were studied. Also, the DIBO complexes 1 a and 2 a can selectively label N‐azidoglycans located on the surface of CHO‐K1 and A549 cells that were pretreated with 1,3,4,6‐tetra‐O‐acetyl‐N‐azidoacetyl‐D‐mannosamine (Ac4ManNAz). Additionally, the intracellular trafficking and localization of these biomolecules were monitored using laser‐scanning confocal microscopy. Interestingly, the biolabeling and cellular uptake efficiency of the DIBO complexes 1 a and 2 a were cell‐line dependent, as revealed by flow cytometry and ICP‐MS. Furthermore, the complexes showed good biocompatibility toward the Ac4ManNAz‐pretreated cells in the dark, but exhibited photoinduced cytotoxicity due to the generation of singlet oxygen.